Horizon’s Adventures in CRISPR land

Add to your list(s) Download to your calendar using vCal

• Dr Nicola McCarthy
• Tuesday 05 December 2017, 14:00-15:00
• Department of Biochemistry, Sanger Building Jean Thomas Lecture Theatre.

If you have a question about this talk, please contact mad58.

CRISPR -Cas9 gene editing has received a lot of publicity over recent years. Often presented as an ‘easy’ route to gene modification, like any other biological process, CRISPR -Cas9 has its advantages and challenges. For drug discovery, CRISPR -Cas9 screens have been touted as the new and improved platform for target identification and validation – perceived to have many advantages and few disadvantages compared with siRNA. This talk will focus on whether this viewpoint is justified and whether CRISPR -Cas9 screens will help to move more robust targets into cancer-specific drug discovery.

This talk is part of the Seminars at the Department of Biochemistry series.

This talk is included in these lists:

• Cambridge Infectious Diseases
• Department of Biochemistry, Sanger Building Jean Thomas Lecture Theatre
• PMRFPS's
• Seminars at the Department of Biochemistry
• biochem seminars
• ndk22's list
• rc781
• se393's list

Note that ex-directory lists are not shown.